P792 Modulation of the fecal metagenome in patients with Crohn's disease

Autor: L. Grande Santamaría, Federico García, N. Chueca Porcuna, J.A. del Campo, H. Pastor Ramírez, Manuel Castro-Fernandez, Maria Rojas-Feria, J.A. Fernández Caballero-Rico, M. Romero-Gόmez

Publikováno v: Journal of Crohn's and Colitis. 11:S485-S485

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fbff7367681010e12e02b0122a15bbb0
https://doi.org/10.1093/ecco-jcc/jjx002.913

AB0478 Optimization of Biological Therapy in a Cohort of Patients with Rheumatoid Arthritis in HURS, CÓrdoba

Autor: M. Cárdenas Aranzana, D. Ruiz Vilchez, S. De la Fuente Ruíz, J. Calvo Gutiérrez, P. Font Ugalde, A. Escudero Contreras, R. Ortega Castro, E. Collantes Estevez, M.C. Castro Villegas, R. Jiménez Gasco, M. Romero Gόmez

Publikováno v: Annals of the Rheumatic Diseases. 74:1057.1-1057

Background Optimization of Biological Therapy (BT) in patients with Rheumatoid Arthritis (RA) in remission, is a strategy employed in rheumatology practice in recent years consisting in dose reduction or enlargement dose interval (1,2) Some published

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::24d96d60bbcde0ba9be1cccb5edc9654
https://doi.org/10.1136/annrheumdis-2015-eular.2606

SAT0145 Long-Term Cost-Effectiveness Analysis of the Treatment with Infliximab, Etanercept and Adalimumab in Rheumatoid Arthritis Patients in Real-Life Clinical Practice

Autor: S. de la Fuente, M.C. Castro-Villegas, Pilar Font-Ugalde, Rafaela Ortega-Castro, Alejandro Escudero-Contreras, Eduardo Collantes, Jerusalem Calvo-Gutiérrez, M. Romero-Gόmez, Miguel A. Casado, D. Ruiz-Vílchez, M. Cárdenas

Publikováno v: Annals of the Rheumatic Diseases. 74:703.2-703

Background Anti-tumour necrosis factor-α agents are effective in the management of rheumatoid arthritis (RA) patients, but superiority among them has not been established. Also, long-term pharmacoeconomic studies examining the cost-effectiveness of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7a15dfce15651a68f9ea912f65896944
https://doi.org/10.1136/annrheumdis-2015-eular.2900

Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.

Autor: Rojas-Feria M; Department of Digestive Diseases, Valme University Hospital, UGC Digestive Disease and CIBERehd, Servicio Andaluz de Salud, Seville E-41014, Spain., Romero-García T; Department of Digestive Diseases, Valme University Hospital, UGC Digestive Disease and CIBERehd, Servicio Andaluz de Salud, Seville E-41014, Spain., Fernández Caballero-Rico JÁ; Complejo Hospitalario Universitario de Granada, Microbiology, Granada E-18016, Spain., Pastor Ramírez H; Institute of Biomedicine of Seville, Digestive Diseases, Hospital Universitario Virgen del Rocío and CIBERehd, Seville E-41013, Spain., Avilés-Recio M; Department of Digestive Diseases, Valme University Hospital, UGC Digestive Disease and CIBERehd, Servicio Andaluz de Salud, Seville E-41014, Spain., Castro-Fernandez M; Department of Digestive Diseases, Valme University Hospital, UGC Digestive Disease and CIBERehd, Servicio Andaluz de Salud, Seville E-41014, Spain., Chueca Porcuna N; Complejo Hospitalario Universitario de Granada, Microbiology, Granada E-18016, Spain., Romero-Gόmez M; Institute of Biomedicine of Seville, Digestive Diseases, Hospital Universitario Virgen del Rocío and CIBERehd, Seville E-41013, Spain., García F; Complejo Hospitalario Universitario de Granada, Microbiology, Granada E-18016, Spain., Grande L; Department of Digestive Diseases, Valme University Hospital, UGC Digestive Disease and CIBERehd, Servicio Andaluz de Salud, Seville E-41014, Spain., Del Campo JA; Department of Digestive Diseases, Valme University Hospital, UGC Digestive Disease and CIBERehd, Servicio Andaluz de Salud, Seville E-41014, Spain. jantonio.delcampo@ciberehd.org.

Publikováno v: World journal of gastroenterology [World J Gastroenterol] 2018 Dec 14; Vol. 24 (46), pp. 5223-5233.